{"gao_id": "GAO-18-15", "published": "2017-10-06T12:00:00Z", "released": "2017-11-06T07:00:00Z", "summary": "More than 14 million people received opioid prescriptions in 2016 through the Medicare drug benefit program, Part D. The Centers for Medicare & Medicaid Services delegate monitoring of these beneficiaries to the private organizations that implement the Medicare Part D benefit. These organizations follow CMS monitoring criteria. While these criteria identify beneficiaries at the greatest risk of harm from opioid use, we found that it...", "title": "Prescription Opioids: Medicare Needs to Expand Oversight Efforts to Reduce the Risk of Harm", "topics": ["Prescription drugs", "Pharmaceutical industry", "Health Care", "Medicare", "Controlled substances", "Substance abuse", "Beneficiaries", "Data collection", "Monitoring", "Drugs", "Reporting requirements", "Internal controls"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-15", "versions": [{"title": "View Full Report Online", "url": "https://files.gao.gov/reports/GAO-18-15/index.html"}, {"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-15-highlights.pdf"}, {"title": "Full Report (35 pages)", "url": "https://www.gao.gov/assets/gao-18-15.pdf"}, {"title": "Accessible PDF (44 pages)", "url": "https://www.gao.gov/assets/690/688693.pdf"}]}